GUWAHATI: The Indian Institute of Technology (IIT) Guwahati alumni-led startup has introduced an advanced point-of-care-testing device named MobilabTM. This indigenous device, incubated at the Research Park and Centre for Nanotechnology at IIT Guwahati, promises to swiftly diagnose chronic diseases related to kidney, liver, heart, and pancreas dysfunctions by testing up to 25 blood parameters.
Designed by M/s Primary Healthtech Pvt. Ltd., with the objective of making diagnostic procedures affordable, accessible, and portable, the IoT-enabled Android app, which operates the device, can conduct about 150 tests on a single battery charge, offering a connected ecosystem suitable for India’s remotest locations.
Central Drugs Standard Control Organisation (CDSCO) has licensed the manufacturing of MobilabTM, which can screen for various parameters including heart, liver, kidney profiles, hematology, and diabetes.
Addressing the alarming global death rates due to non-communicable diseases (NCDs) – which the World Health Organization (WHO) reports as approximately 41 million (74%) annually – MobilabTM’s innovation can significantly reduce these numbers. Its ability to provide early screening and cost-effective disease management is expected to benefit millions annually.
The device is equipped to deliver real-time data within 10 minutes, producing digital reports and electronic health records which can be seamlessly shared with healthcare professionals. Among its diverse features are – portability with lightweight design and battery operation, accuracy levels matching gold-standard devices a,d user-friendly interface, among others.
Currently, MobilabTM has been endorsed by renowned hospitals, including Guwahati Medical College & Hospital, Guwahati Neurological Research Centre, Army Hospital, AIIMS New Delhi, and has already been implemented in several Indian states like Assam, Maharashtra, Uttar Pradesh, and Delhi.
Expressing his enthusiasm, Sahil Jagnani, an IIT Guwahati alumnus and Founder and CEO of Primary Healthtech, said, “MobilabTM aims to provide fellow citizens with affordable diagnostic solutions while expediting early screening, disease management, and treatment. It’s also anticipated to promote the ‘Make-in-India’ initiative.”
The device has earned accolades such as the National Start-Up Award 2022, ISO certifications, and has been supported by various institutions including the Centre for Nanotechnology, IIT Guwahati, and Start-Up India.